Pharmacokinetics and Safety of BILR 355 in Healthy Male Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Boehringer Ingelheim
Related studies linked through entity extraction aliases.
Dose Escalation Study of Pharmacokinetics, Safety and Tolerability After Single Dose Administration of BILR 355 (SDS) Plus Low-dose Ritonavir in Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Dose Escalation Study of the Safety, Tolerability and Pharmacokinetics of BILR 355 BS Plus Low Dose Ritonavir in HIV-uninfected Male Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Pharmacokinetic Interaction Between TRUVADA™ and BILR 355 BS Plus Ritonavir in Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Bioequivalence Study of Tipranavir Stored at Controlled Temperature Compared With Tipranavir Stored at Controlled Refrigerated Conditions, Orally Co-administered With Ritonavir in Healthy Male and Female Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Study to Determine the Effects of Multiple-dose Omeprazole on the Single-dose Pharmacokinetics of Tipranavir (TPV) Coadministered With Ritonavir (RTV) in Healthy Adult Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Pharmacokinetic of Tadalafil Co-administered With Tipranavir/Ritonavir to Healthy Male Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Effects of TPV/r on the Pharmacokinetics of Carbamazepine in Healthy Adult Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Pharmacokinetic Study in Healthy Adult Volunteers to Assess the Interactions Between Steady-State Tipranavir and Atazanavir in the Presence of Ritonavir
- Status
- COMPLETED
- Phase
- PHASE1
Multiple Dose Comparison of the Effect of Two Dose Combinations of Tipranavir/Ritonavir (TPV/RTV), on the Pharmacokinetic Characteristics of Efavirenz (Sustiva®) in Healthy Adult Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Pharmacokinetics of Tipranavir/Ritonavir and Its Metabolites in Healthy Male Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Evaluation of the Pharmacokinetic Interaction of Steady State Tipranavir and Ritonavir or Tipranavir and Ritonavir With Single Dose Didanosine in Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Effects of Steady State Tipranavir/Ritonavir or Darunavir/Ritonavir or Ritonavir on Platelet Function, Coagulation and Fibrinolysis Biomarkers in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Effects of Single-dose and Steady-state TPV/r on the Steady-state Pharmacokinetics of Clarithromycin and a Preliminary Assessment of the Effects of a Standard High-fat Test Meal on the Steady-state Pharmacokinetics of Tipranavir
- Status
- COMPLETED
- Phase
- PHASE1
Effects of Tipranavir/Ritonavir on the Pharmacokinetic Characteristics of Triple Drug Nucleoside and Non-nucleoside Reverse Transcriptase Inhibitor Therapy in HIV-1-infected Subjects
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Efficacy and Safety of BIIL 284 BS in Adult Patients With Active Rheumatoid Arthritis
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Tolerability of BIII 890 in Patients With Acute Ischemic Stroke
- Status
- COMPLETED
- Phase
- PHASE2
Pharmacokinetics of Dipyridamole Administered as Aggrenox® (Dipyridamole Extended Release Plus Aspirin) Capsule Versus Dipyridamole Immediate Release Plus Aspirin Following Alteration of Stomach pH
- Status
- COMPLETED
- Phase
- PHASE4
Effects of Steady-state TPV/RTV on the Single-dose Pharmacokinetics of Rifabutin and the Effects of Single-dose Rifabutin on the Steady-state Pharmacokinetics of TPV in Healthy Adult Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Bioavailability of Tipranavir/Ritonavir Paediatric Solution Compared to Tipranavir/Ritonavir Capsules in Healthy Female and Male Subjects
- Status
- COMPLETED
- Phase
- PHASE1